Drug Type Small molecule drug |
Synonyms- |
Target |
Action antagonists |
Mechanism P2X4 receptor antagonists(P2X purinoceptor 4 antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC17H11BrN2O2 |
InChIKeyANFGFBGFAXCROQ-UHFFFAOYSA-N |
CAS Registry397881-13-9 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Pain | Preclinical | Italy | 27 Mar 2025 |